| Tittel: | Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: what’s known so far | | Ansvar: | David Richard Walwyn | | Forfatter: | Walwyn, David Richard  | | Materialtype: | Artikkel - elektronisk | | Signatur: | WIPO Magazine | | Utgitt: | Geneva : WIPO, 2021 | | Omfang: | S. 6-9 | | ISBN/ISSN: | 1564-7854 | | Serie: | WIPO Magazine ; 4/2021 | | Emneord: | Bioteknologi / Korona - COVID-19 / Pandemi / Vaksine | | Geografiske emneord: | Rwanda / Senegal / Singapore | | Note: | Open access Attribution 4.0 International (CC BY 4.0) | | Innhold: | The lack of vaccine production capacity in African countries has been the subject of much concern and hand-wringing in the wake of the COVID-19 pandemic. It has become a particularly hot topic because of the gravely unequal access to COVID-19 vaccines between developed and developing countries.
Africa has limited capacity for vaccine production. Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines. The largest and most integrated facility is the Biovac Institute in Cape Town. | | Del av verk: | WIPO Magazine 4/2021 |
|
|